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3) Nunome S., Kiyohara H., Komatsu K., and Takeda T.: Crude Drugs of Juzen-taiho・to,In 
Juzen-taiho・to(Shi-Quan-Da-Bu-Tang) Scientific Evaluation and Clinical Applications, by 
Yamada H., and Saiki I. (Ed.) 7-56, Taylor & Francis, Boca Raton, 2005. 




光光度法を用いた漢薬「石膏Jの溶出量に関する研究.J. Trad. Med., 22: 24・28,2005. 
Abstract: "Shigao （石膏）”isone of the Chinese mineral drugsラderivedfrom calcium sulfate dihydrate 
(Gypsum, CaS04・2H20),which has been used as antipyretic for heat in the lung with high fever and dire 
thirst. In generalヲJapaneseKampo or Chinese medical doctors have made allowance for the amount of 
gypsum according to symptom complex of patients when they make decoctions of some formulations 
such as Byakko-ka-ninjin-to. However, the dissolution rate of gypsum with increasing amount was not 
clear. We extracted gypsum with hot water to measure the concentration of calcium using the atomic 
absorption spectrometry. The results showed that the calcium concentration was approximately 200 ppm 
when 10 g of block form of gypsum was used for one hour extraction and the dissolution rate was 
increased depending on the amount of gypsum and the length of extraction time. However, in the case of 
the powder form of gypsum, the calcium concentration was approximately 5 50 ppm for 15 min extraction 
and the dissolution rate was almost constant, independent of the amount of gypsum and extraction time. 
Thus, the block form of gypsum is better to use in order to be able to control the dissolution rate. 
Moreoverラaccordingto X-ray diffraction method and fluorescent X-ray analysis, the crystal structures 
and the contents of inorganic compounds were not changed before and after extraction, suggesting that 
the block form of gypsum has possibility to be used several times. 
2) Kuboyama T., Tohda C., and Komatsu K.: Neuritic regeneration and synaptic 
reconstruction induced by withanolide A. Br. J. Pharmacol., 144: 961-971, 2005. 
Abstract: We investigated whether withanolide A (WL-A), isolated from the Indian herbal drug 
Ashwagandha (root of Withania somnifera), could regenerate neurites and reconstruct synapses in 
severely damaged neurons. We also investigated the effect of WL-A on memory-deficient mice showing 
neuronal atrophy and synaptic loss in the brain. Axons, dendrites, presynapses, and postsynapses were 
visualized by immunostaining for phosphorylated neurofilament-H (NF-H), microtubule-associated 
protein 2 (MAP2), synaptophysin, and postsynaptic density-95 (PSD-95), respectively. Treatment with 
Af3(25-35) (10 μM) induced axonal and dendritic atrophy, and pre-and postsynaptic loss in cultured rat 
cortical neurons. Subsequent treatment with WL-A (1 μM) induced significant regeneration of both axons 
and dendrites, in addition to the reconstruction of pre-and postsynapses in the neurons. WL-A (10 
μmol/kg/day, for 13 days, p・o.)recovered Af3(25・35）ーinducedmemoηr deficit in mice. At th剖 time,the 
decline of axons, dendrites, and synapses in the cerebral cortex and hippocampus was almost recovered. 
WL-A istherefore an important candidate for the therapeutic treatment of neurodegenerative diseases, as 
it is able to reconstruct neuronal networks. 
28 
3) Goto H., Sasaki Y., Fushimi H., Shibahara N., Shimada Y., and Komatsu K.: Effect of 
Curcuma Herbs on Vasomotion and Hemorheology in Spontaneously Hypertensive Rat. Am. 
J. Chin. Med., 33: 449-457, 2005. 
Abstract: Curcuma herbs have a vasodilator effect. The effects of C. longα，which induces only 
endothelium-independent vasodilatation, and C. zedoaria, which induces both endothelium-dependent 
and -independent vasodilatation, were studied on vasomotion and hemorheology in spontaneously 
hypertensive rats. Spontaneously hypertensive eight-week-old male rats were assigned to five groups. For 
12 weeks, the control group received standard chow. The 3% CL (C. longa) group received standard chow 
containing 3% (wt/wt) C. longa. The 1 % CZ and 3% CZ (C. zedoaria) groups received standard chow 
containing 1%and3% (wt/wt) C. zedoaria, respectively. The captoril group received standard chow and 
100 mg/kg/day of captoril in drinking water. Blood pressure, vasomotionラ hemorheology,etc. were 
examined. Systolic blood pressure of the 3% CZ and captoril groups decreased significantly as compared 
to the control group. Acetylcholine-induced endothelium-dependent relaxations of the 3% CZ and 
captoril groups were increased to a greater degree, significantly, than the control group. When testing 
xanthine oxidase-induced contraction, the 3% CZ group was significantly decreased as compared to the 
control group. Low shear stress of whole blood viscosity showed the 3% CL and 3% CZ groups to be 
decreased significantly compared to the control group. Thus, Curcuma herbs have hypotensive and 
protective effect on the endothelium in spontaneously hypertensive rats. Especially, C. zedoaria is more 
effective than C. longa, and its mechanism is thought to be related to a radical scavenging effect and 
improvement of hemorheology. 
4) Jo M., Nakamura N., Kurokawa M叫 KomatsuK., Shiraki k叫 andHattori M.: Anti-herpes 
simplex virus activities of traditional Chinese medicines, used in Yunnan and Tibetan 
provinces of China. J. Trad. Med., 22: 321・328,2005. 
Abstract: One hundred and sixty-eight traditional Chinese medicines collected in the Yunnan and 
Tibetan provinces were screened for their anti-herpes simplex type 1 (HSV-1) activity by using a plaque 
reduction assay using Vero cels. Of these, 24 extracts exhibited appreciable inhibitory activities against 
HSV-1. They were further examined for their therapeutic efficacies in mice infected with HSV-1; mice 
were infected cutaneously with HSV-1 and the extracts were orally administrated three times daily. 
Among them, nine extracts of Terminalia chebula (T42), Tripterygium hypoglaucum (Y 42M), and 
Moghania phi!伊pinensis(Y86M), and a water extract of Tトipterygiumhypoglaucum (Y44H) delayed the 
development and progression of skin lesions. Methanol extracts of Cassia巴βstula(T59), and 
Choerospondias exillaries (T73), and water extracts of Begonia eναnsiana (Y27H), Maytenus fookerii 
(Y60H) and Potentilla grif.fithi (Y63H) showed therapeutic effects. These extracts may be candidates for 
the development of anti-HSV-1 compounds. 
5) Zhang Y., Li J.-X., Zhao J., Wang S.-Z., Pan Y., Tanaka K., and Kadota S.: Synthesis and 
activity of oleanolic acid derivatives, a novel class inhibitors of osteoclast formation. Bioorg. 
Med. Chem. Letι，15: 1629・1632,2005. 
Abstract: Two series of oleanolic acid derivatives were synthesized and their inhibitory activity on the 
formation of osteoclast-like multinucleated cells (OCLs) induced by 1α，25-dihydroxy vitamin D3 was 
evaluated in a co-culture assay system. The structure-activity relationships, together with electronic 
structure based on the frontier molecular orbitalsラforexample, HOMO and LUMO, related to different 
amino acid substituents were studied. Derivatives with proline or phenylalanine showed a tendency to 
enhance the inhibitory activity. 
6) Linn T.Z., Awale S., Tezuka Y., Banskota A.H., Kalauni S.K., Attamimi F., Ueda J., Asih 
P.B.S., Syafruddin D., Tanaka K., and Kadota S.: New Cassane-and Norcassane-type 
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Diterpenes from Caesalpinia crista of Indonesia. J. NaιProd., 68: 706四710,2005. 
Abstract: The CH2Ch extract of the seed kernels of Caesa争iniacrista, which exhibited promising 
antimalarial activity against Plasmodium berghei-infected mice inνivo, was examined and resulted in the 
isolation of seven new furanocassane-type diterpenes [ caesalpinins C-G (1-5) and norcaesalpinins D and 
E (6ラ 7)]together with norcaesalpinins A-C (8-10) and 1 known compounds (norcaesalpinins A-C, 
2-acetoxy-3-deacetoxycaesaldekarin e, caesalmin B, caesaldekarin e, caesalpin F, 
14( 17)-dehydrocaesalpin F, 2-acetoxycaesaldekarin e, 7-acetoxybonducellpin C, and caesalmin G). Their 
structures were determined on the basis of spectroscopic analysis. The isolated diterpenes showed 
significant dose-dependent inhibitory effects on Plasmodiumfalc伊arumFCR-3/A2 growth in vitro. Their 
IC50 values ranged from 90 nM to 6.5 μM, and norcaesalpinin E (7) showed the most potent inhibitory 
activity (IC50, 90 nM). 
7) Awale S., Kawakami T., Tezuka Y., Ueda J., Tanaka K., and Kadota S.: Nitric Oxide (NO) 
production Inhibitory Constituents of Tabebuia avellanedae from Brazil. Chem. Pharm. 
Bull., 53: 710咽713,2005. 
Abstract: From the water extract of Brazilian Tabebuia avellanedae, two new iridoids (1ラ2)and a new 
phenylethanoid glycoside (3) have been isolated together with twelve known compounds (4-15). Their 
structures were determined based on the spectroscopic data. The isolated compounds inhibited nitric 
oxide (NO) production in lipopolysaccharide (LPS)-activated macrophage-like 1774.1 cells. Compounds 
1, 3, 10, 11, and 12 showed inhibitory activities more potent (IC50, 13.8-26.1 μg/ml) than a positive 
control lf'-monomethyl四L-arginine(L-NMMA; IC50, 27.4 μg/ml). 
〈〉総説
1) Komatsu K., Yang D. Y.ラFushimiH., and Cai S. Q.: Authentication ofRhei Rhizoma. J. Trad. 
Med.ラ22(Suppl. 1): 70-85, 2005. 
2) Tohda C., Komatsu K., and Kuboyama T.: Scientific basis for the anti-dementia drugs of 
constituents from Ashwagandha (Withania somnifera). J. 1均d.Med., 22 (Suppl. 1): 176・182ラ
2005. 
3) Komatsu K., Tohda C., and Zhu S.: Ginseng drugs -Molecular and Chemical Characteristics and 
Possibility as Antidementia Drugs. Current Topics in Nutraceutical Research, 3: 47-64, 2005. 
4) Tohda C., Kuboyama T., and Komatsu K.: Search of natural products related to regeneration of the 
neuronal network. Neurosignals, 14: 34-45, 2005. 
〈〉学会報告（＊：特別講演，シンポジウム，ワークショップ等）














6) Takahashi K., Komatsu K. and Azuma J.: An approach to the in vitro evaluation of potential for 
CYP3A4 induction: Implication for pharmacokinetic herb-drug interaction. 2005’International 
Symposium in Beijing on Pharmacognosy, 2005, 5.13-14, Beijing, China. 
7) Komatsu K., Sasaki Y., Fushimi H., Tohda C., Goto H., Shibahara N. and Terasawa K.: Molecular 
analysis, identification and quality evaluation of Curcuma drugs from China and Japan. 2005’ 










12) 久保山友晴，東田千尋，小松かつ子： Restorationfrom neurodegenerative changes by 
withanoside IV and by its active metaboliteラsomin one.第48回日本神経化学会，2005,9/28-29, 
福岡．
13) 中西類子，東田千尋，橋本斎，小松かつ子，横津隆子： Metabolite1 of protopanaxadiol勾pe
saponins, an axonal regenerative factor, stimulates teneurin-2 followed by PB-kinase cascade.第
48回日本神経化学会， 2005, 9/28-29，福岡．
14) 表貴之，木台友紀， ShuZhu，小松かつ子，御影雅幸： Ephedrα属植物の遺伝子解析と




成分の模討．日本生薬学会第 52回年会， 2005, 9.16-17，金沢．
16) 丸山卓郎，合田幸広，小松かつ子，川崎武志，藤田正雄，近藤健児，寺林 進，嶋田宏
志，山本豊： ITS塩基配列によるシゴカの墓原種鑑別．日本生薬学会第 52回年会， 2005,
9.16-17，金沢．
* 17) Komatsu K.: Genetic and chemical diversity of Chinese medicinal plants: Panαx and Rheum. 日
本植物学会第69回大会，シンポジウム” Metabolicdiversity of indigenous plants in A仕ica，”
2005, 9.20-23，富山．
18) Wongpanich V., Ruangrungsi N., and Komatsu K.: Organizing Thai crude drug database: What to 
do with the vernacular names of samples. The 2nd AASP Symposium & 2nd APEM Conference 
2005,2005, 11.14」7,Bangkok, Thailand. 
* 19) Komatsu K., and Zhu S.: Workshop on Identification of Herbal Drugs by Molecular Methods.北
京大学薬学院，21世紀COEプログラム， 2005,11.28-12ム北京，中華人民共和国．
20) Komatsu K.: Identification of Herbal Drugs by Molecular Technology: Background, Rationale, 
Significance, Impact. Workshop on Identification of Herbal Drugs by Molecular Methods, 21世
紀 COEプログラム， 2005,11.28-12.2，北京，中華人民共和国．
21) Zhu S.: General Principle of DNA Technology for Authentication of Herbal Drugs. Workshop on 
Identification of Herbal Drugs by Molecular Methods, 21世紀 COEプログラム， 2005,
11.28-12ム北京，中華人民共和国．
22) Komatsu K.: Recent Research on Genus Curcumα：Molecular Analysis, Identification and Quality 
Evaluation on Vasomotion Effect. Workshop on Identification of Herbal Drugs by Molecular 
Methods, 21世紀COEプログラム， 2005,11.28-12.2，北京，中華人民共和国．
23) Zhu S.: Pharmacognostical Study on Ginseng Drugs ・ Phylogenetic Analysis, Molecular 





1) 小松かつ子：医食同源の思想と茶「特集飲む一一服の悔しみJ.月刊みんぱく， 29(5):5-6, 
2005. 
講演等
2) 小松かつ子：モンゴルの有用生物資源．富山漢方会， 2005, 3.11，富山．





6) 小松かつ子：学術の森「踏鞭会」に原点、あり．富山新聞， 2005, 7.20，富山．
7) 小松かつ子：体験実習2. 生薬方剤の鑑定．第 10田和漢薬研究所夏期セミナー， 2005,
8.24-26，大山町．
8) 小松かつ子：加賀・能登の薬草シンポジウム（第6回），薬草観察会.2005, 10.9，加賀．

































1) 察 少青：北京大学薬学院， JavzanBatkhuu：国立モンゴル大学生物学部， Sitthithawom
Worapan : Srinakarinwirot大学薬学部，服部征雄，東田千尋，中村憲夫：富山大学和漢医
薬学総合研究所，「アジアにおける漢薬資源の調査と薬用植物の多様性の解析J.2005～ 
2) Suchada Sukrong: Chulalongkom大学薬学部，「MolecularAnalyses of the Genus MitragaynaJ, 
2005 
〈〉研究費取得状況





















外国人客員研究員： SuchadaSukrong (Chulalongkom University, 2005, 10.11～12. 5，拠点大学方式
学術交流事業）
〈〉学位（修士，博士）取得者
卒業論文：
大家真由子： Eleutherococcus属植物の遺伝子解析と刺五加の墓源と毘質に関する研究
木谷友紀：均hedra属植物の遺伝子解析とモンゴル産同属植物の有用性に関する研究
33 
修士論文：
市村真帆子：刺五加 （Eleutherococcussenticosusの根）によるシナプス再形成を機序とし
た抗痴呆作用の研究
表 貴之：日本導入Rheum属植物の墓源と昂質に関する研究
劉 洪宇：抗歯周病活性を有する和漢薬及びその成分に関する研究
〈〉人事移動
田中謙：問教授（2005.7. 1採用）
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